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ㅋ
Background/Aims
SCN5A encodes the cardiac-specific NaV1.5 sodium channel, and Brugada syndrome is a cardiac conduction disorder asso-
ciated with sodium channel α-subunit (SCN5A) mutation. The SCN5A-encoded NaV1.5 channel is also found on gastro-
intestinal smooth muscle and interstitial cells of Cajal. We investigated the relationship between functional dyspepsia (FD) and 
SCN5A mutation to evaluate sodium channelopathy in FD.
Methods
Patients with Brugada syndrome or FD were examined using upper endoscopy, electrogastrography (EGG), FD symptom ques-
tionnaire based on Rome III criteria and genetic testing for SCN5A mutation. Symptom scores of FD and EGG findings were 
analyzed according to SCN5A mutation.
Results
A total of 17 patients (4 Brugada syndrome and 13 FD) participated in the study. An SCN5A mutation was noted in 75.0%  
of the patients with Brugada syndrome and in 1 (7.7%) of the patients with FD. Of 4 patients with SCN5A mutation, 2 (50%) 
had FD. Postprandial tachygastria and bradygastria were noted in 2 (50%) and 1 (25%) of the patients with SCN5A mutation, 
respectively. The EGG findings were not significantly different between positive and negative mutation in 17 patients.
Conclusions
Although we did not find statistically significant results, we suggest that it is meaningful to attempt to identify differences in  
symptoms and gastric myoelectric activity according to the presence of an SCN5A mutation by EGG analysis. The relationship 
between FD and sodium channelopathy should be elucidated in the future by a large-scale study.
(J Neurogastroenterol Motil 2012;18:58-63)
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Figure. Arrhythmogenic pathogenetic pathway for Brugada syndrome and possible mechanism of functional dyspepsia (FD). aThe genetic 
abnormality in the cardiac sodium channel SCN5A causes a molecular phenotype of increased late sodium current which causes a cellular phenotype 
of prolonged action potential duration as well as early after depolarizations (Modified from Makielski13). Prolonged action potential in the cells of the
ventricular myocardium produces tissue/organ phenotype of a prolonged QT interval on the electrocardiogram and torsade de pointes arrhythmia in
the whole heart. If this is sustained or degenerates to ventricular fibrillation, the clinical phenotype of Brugada syndrome results. bIn interstitial cell of 
Cajal and gastrointestinal smooth muscle cells, sodium flux through the sodium channel regulates membrane potential and slow-wave frequency, 
suggesting that the channel may participate in the regulation of gastrointestinal motility. Therefore, mutation of the SCN5A gene may lead to 
abnormalities of gastric myoelectrical activity. Several reports suggest a close relationship between myoelectrical abnormalities and dyspeptic symptoms.
Based on these information, our study was to present channelopathy as one of the pathophysiologic mechanism of FD. INa, sodium current; ICC, 
interstitial cell of Cajal; GI, Gastrointestinal.
Introduction
Functional dyspepsia (FD) is a common clinical syndrome 
consisting of recurrent or persistent abdominal symptoms of epi-
gastric pain and fullness, early satiety, nausea, and/or vomiting in 
the absence of an organic cause.1,2 The pathophysiology of func-
tional dyspepsia remains unclear, and many researchers have fo-
cused upon the following factors: gastric motor function, visceral 
sensitivity, Helicobacter pylori infection, and psychosocial factors. 
Among these, motility abnormalities of the stomach and upper 
small bowel have been found in the majority of patients with un-
explained dyspepsia.2
Understanding on the control of gastrointestinal (GI) mo-
tility was greatly improved by the discovery that a specialized cell 
type, the interstitial cell of Cajal (ICC), is also required for coor-
dinated motility.3-6 The ICC is an electrically active cell and gen-
erates the slow waves which play an important role in gastric 
motility.3,4 In ICC and intestinal smooth muscle cells, there are 
sodium channel α-subunit gene (SCN5A) encoded sodium chan-
nels as well as KCNH2-encoded HERG potassium channels, 
which are associated with congenital long QT syndrome. It has 
been reported that there is no association between KCNH2 geno-
type status and GI symptoms, whereas patients with mutations in 
SCN5A have a higher prevalence of GI symptoms.7
The sodium channel encoded by SCN5A has been described 
in human intestinal ICC and smooth muscle cells.8-11 In these 
studies, it was revealed that sodium flux through the sodium 
channel regulates membrane potential and slow-wave frequency, 
suggesting that the channel may participate in the regulation of 
GI motility. SCN5A also encodes the cardiac sodium channel re-
sponsible for the rapid depolarization of the cardiac action poten-
tial, and Brugada syndrome has been reported to be related to 
mutation of this gene (Figure).12
Therefore, we hypothesized that mutation of the SCN5A 
gene may lead to abnormalities of gastric myoelectrical activity in 
patients with Brugada syndrome. To test this hypothesis, we 
measured an electrogastrography (EGG) for detection of gastric 
myoelectrical activities and collected dyspeptic symptom ques-
tionnaires from patients with Brugada syndrome and functional 
dyspepsia. Additionally, we evaluated FD patients without 
Brugada syndrome in the same methods for comparison.
Materials and Methods
Subjects and Clinical Data
Patients with Brugada syndrome were recruited from the 
Yonsei Cardiovascular Genome Center from June 2008 to No-
vember 2010. Patients with FD were recruited from Gangnam 
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Severance Hospital over the same period. The protocol for this 
study was approved by Yonsei Medical Center Institutional 
Review Committee (3-2008-0066) in compliance with the Decla-
ration of Helsinki, and the study was carried out under its 
guidelines. Informed consent was obtained from all participants.
The diagnosis of Brugada syndrome was based on a 12-lead 
ECG with the following ECG parameters: (1) at least a 2 mm 
ST-segment elevation in more than one right precordial lead (V1 
to V3) with a right bundle branch block morphology and (2) a 
J-wave elevation ＞ 0.2 mV at baseline. The absence of a struc-
tural abnormality was confirmed by echocardiography. Patients 
confirmed Brugada syndrome received FD questionnaires, es-
phagogastoduodenoscopy, and genetic analysis of SCN5A from 
peripheral blood.
The diagnosis of FD was based on esophagogastroduodeno-
scopy and FD questionnaires. Participants diagnosed with FD 
were enrolled, and they were checked by ECG to exclude in-
cidental co-morbidity of Brugada syndrome. Enrolled patients 
received EGG and genetic analysis of SCN5A from peripheral 
blood.
Questionnaires for Functional Dyspepsia
FD was diagnosed according to Rome-III criteria. Symp-
toms of epigastric pain, epigastric burning, postprandial fullness, 
early satiety, postprandial bloating and postprandial nausea or ex-
cessive belching were scored in accordance with the following 
scheme: 0 = none, 1 = mild (symptom could be ignored if the 
patient did not think about it), 2 = moderate (symptom could not 
be ignored but did not influence daily activities) and 3 = severe 
(symptom influenced daily activities). Symptom severity scores 
were added (minimum: zero to maximum 18). The frequency of 
dyspeptic symptoms described above was scored in accordance 
with the following scheme: 0 = none, 1 = once or twice in one 
month, 2 = once or twice in one week and 3 = above 3 times in a 
week. Scores were added (minimum: zero to maximum 18). 
Patients with FD were classified into 2 subtypes, PDS and EPS.
Electrogastrography
An ambulatory EGG (Digitrapper EGG, Synetics Medical 
Inc., Stockholm, Sweden) with active electrodes was used to re-
cord gastric myoelectrical activity. EGG was recorded in the 
morning after an overnight fast. To reduce the resistance between 
electrode and skin, conduction cream (Signa CremeⓇ, Parker 
Laboratories, Fairfield, NJ, USA) was applied to the skin after 
shaving the hair on the abdomen and performing abrasion with 
skin prepping paste (Omni PrepⓇ, DO Weaver & Co., Aurora, 
CO, USA). One active recording electrode was placed in the 
ventral midline halfway between the xiphoid process and um-
bilicus, a second active recoding electrode was placed 6 cm to the 
left of the first electrode, 45o cephalad, and a third reference elec-
trode was placed to the right of the first electrode. The 3 electro-
des were connected to the Digitrapper EGG recording device. 
EGG of the preprandial period was recorded for 30 minutes be-
fore a meal, and EGG of the postprandial period was recorded 
for 30 minutes after a meal, with the patient in a sitting position, 
reclining at a 45o angle in a comfortable chair. Solid meals (rice 
rolled up in dried seaweed with orange juice) were given to 
patients. All recording data were uploaded into a personal com-
puter and analyzed by a software program (Polygram for Win-
dows version 6.40, Synetics Medical Inc., Stockholm, Sweden).
EGG recording data were analyzed according to the follow-
ing parameters: (1) percentage of normal gastric slow waves 
(approximately 2.0-4.0 cycle/min), bradygastria (1.8-2.0 cycle/ 
min) and tachygastria (4.0-10.0 cycle/min); and (2) the ratio of 
postprandial to fasting dominant power.
Genetic Analysis of SCN5A
The mutation analysis was carried out by polymerase chain 
reaction (PCR) followed by direct sequencing. Genomic DNA 
was extracted from peripheral blood leukocytes using QIAampⓇ 
DNA blood kits (Qiagen, Valencia, CA, USA). The PCR was 
performed using modified primers to sites located in the intronic 
sequences and amplification conditions as previously described.14 
The amplified products were purified using QIAquickⓇ PCR 
purification kits (Qiagen) and directly sequenced using ABI 
PRISM Big Dye Terminator Cycle Sequencing Ready Reaction 
kits and an ABI PRISM 3730xl DNA analyzer (Applied 
Biosystems, Foster City, CA, USA). Sequences were compared 
with the reference genomic and cDNA sequences of SCN5A 
(GenBank accession numbers NT 022517.17 and AY148488.1, 
respectively) using BLASTN.
Statistical Methods
Questionnaire scores and parameters recorded by EGG were 
statistically analyzed by the Mann-Whitney U test and Fisher’s 
exact test using SPSS 17.0. A P-value of less than 0.05 was con-
sidered significant.
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Table 1. Patient Characteristics and Symptom Scores
Case 
number 
Age/Sex 
SCN5A 
mutation 
Subtype 
of FD 
Symptom score 
Severity Frequency
Brugada syndrome 
    No. 1  29/M  +  PDS  7  6
    No. 2  49/M  + 　-  3  3
    No. 3  58/F  + 　-  1  1
    No. 4  49/M  -  EPS  7  5
Functional dyspepsia 
    No. 5  58/F  +  PDS  5  7
    No. 6  23/F  -  PDS  8  7
    No. 7  37/F  -  PDS  11  15
    No. 8  31/F  -  PDS  14  14
    No. 9  20/M  -  PDS  7  7
    No. 10  37/F  -  PDS  11  13
    No. 11  20/M  -  PDS  6  8
    No. 12  69/F  -  EPS  11  13
    No. 13  26/F  -  EPS  3  6
    No. 14  53/F  -  EPS  6  12
    No. 15  70/M  -  PDS  8  10
    No. 16  36/M  -  PDS  14 14
    No. 17  49/F  -  EPS  9  10
FD, functional dyspepsia; PDS, postprandial distress syndrome; EPS, 
epigastric pain syndrome.
Table 2. Electrogastrographic Findings According to SCN5A Mutation
Case number 
Power ratio
(postprandial/preprandial) 
Preprandial perioda Postprandial perioda
Bradygastria Normal Tachygastria Bradygastria Normal Tachygastria
SCN5A mutation (+)
    No. 1 1.0   9.1 90.9   0.0 75.0       0.0 25.0
    No. 2 4.0   0.0 85.7 14.3   0.0     66.7 33.3
    No. 3 0.4 15.8 84.2   0.0   6.7     60.0 33.3
    No. 5 0.2   0.0 71.4 28.6   0.0     87.5 12.5
    Mean ± SD 1.4 ± 1.7 6.2 ± 7.7 83.0 ± 8.3 10.7 ± 13.7 20.4 ± 36.5 53.5 ± 37.6 26.0 ± 9.8
SCN5A mutation (-)
    No. 4 1.0 11.8 52.9 35.3 10.0     70.0 20.0
    No. 6 0.4   0.0 100   0.0   8.3     75.0 16.7
    No. 7 0.0 25.0 75.0   0.0   5.9     76.5 17.6
    No. 8 0.6 62.5 25.0 12.5 57.1     42.9   0.0
    No. 9 N/A   0.0   0.0 20.0   0.0     55.6 11.1
    No. 10 0.9 25.0 25.0 50.0   7.7     69.2 23.1
    No. 11 0.0   0.0 71.4 28.6 10.0     65.0 25.0
    No. 12 1.3 23.5 35.3 41.2   6.7     93.3   0.0
    No. 13 0.6   0.0 57.1 42.9   0.0     87.5 12.5
    No. 14 1.4 41.7 58.3   0.0   0.0     50.0 50.0
    No. 15 1.6   0.0 84.6 15.4 18.8     56.3 25.0
    No. 16 2.1 20.0 60.0 20.0   0.0   100.0   0.0
    No. 17 0.1   9.1 63.4 54.5   0.0   100.0   0.0
    Mean ± SD 0.8 ± 0.7 16.8 ± 19.1   54.5 ± 27.2 24.6 ± 19.1   9.6 ± 15.3 72.4 ± 18.7    15.5 ± 14.3
aData are expressed as percentage.
N/A, not assessable.
Results
Patient Characteristics
Four patients with Brugada syndrome were enrolled in this 
study (Table 1). Of 4 patients with Brugada syndrome, 3 were 
male and 1 was female. Their ages were between 29 and 59 years. 
SCN5A mutation was found in 3 patients (75%), one of whom 
met diagnostic criteria for a postprandial distress syndrome 
(PDS) subtype of FD.
Thirteen patients with FD were enrolled (Table 1). Four 
were male and 9 were female. Their ages were between 20 and 69 
years. Nine patients had a PDS subtype and 4 had a EPS 
subtype. SCN5A mutation was found in only 1 patient with a 
PDS subtype of FD (7.7%).
Of 4 patients with SCN5A mutation, 2 (50%) had FD with a 
PDS subtype.
The severity and frequency of symptom scores are described 
in Table 1. Since number of patients was small, we could not find 
specific symptom patterns according to mutation of SCN5A in 
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Table 3. Comparison of the Electrogastrographic Results Between the SCN5A Mutation Negative and Positive Groups
SCN5A
P-value 
Mutation (-) (n = 13) Mutation (+) (n = 4)
Preprandial period Bradygastria   2 (15.4%)  0 (0.0%) 0.120 
Normal   5 (38.4%)  4 (100.0%) 
Tachygastria   6 (46.2%)  0 (0.0%) 
Postprandial period Bradygastria   2 (15.4%)  1 (25.0%) 0.099 
Normal 10 (76.9%)  1 (25.0%) 
Tachygastria   1 (7.7%)  2 (50.0%) 
patients with Brugada syndrome and FD.
Electrogastrography Parameters
The EGG results of each patient are described in Table 2. 
Four patients (3 Brugada syndrome and 1 FD) had SCN5A mu-
tation in our study. Case 1 (No. 1) was a 29-year-old male who 
had Brugada syndrome associated with the PDS subgroup of 
FD. Power ratio (PR) at 3 cycle/min was 1.0. In the preprandial 
period, most of the frequency was in the normal range (90.9%). 
However, in the postprandial period, the dominant frequency 
changed to bradygastria (75%). Case 2 (No. 2) was a 49-year-old 
male with Brugada syndrome without GI symptoms. PR at 3 cy-
cle/min was 4.0, and 85.7% of the waves were in the 2-4 cy-
cle/min range in the preprandial period. However, he had post-
prandial tachygastria (33.3%). Case 3 (No. 3) was a 58-year-old 
female who has Brugada syndrome without FD, but PR at 3 cy-
cle/min was decreased to 0.4. She had normal slow waves (85.2%) 
in the preprandial period, and tachygastria (33.3%) in the post-
prandial period. Case 4 (No. 5) was a 58-year-old female who 
had a PDS subtype of FD without Brugada syndrome. PR at 3 
cycle/min was decreased to 0.2, but the dominant frequency was 
in the normal range in the pre-prandial (71.4%) and post-pran-
dial (87.5%) periods, respectively.
Postprandial tachygastria and bradygastria were noted in 2 
(50%) and 1 (25%) of 4 patients with SCN5A mutation, respec-
tively.
In the SCN5A mutation negative group (12 FD and 1 
Brugada syndrome), 2 patients were bradygastric (15.4%), 5 pa-
tients were normal (38.4%) and 6 patients were tachygastric 
(46.2%) in the preprandial period. In addition, 2 patients were 
bradygastric (15.4%), 10 patients were normal (76.9%) and 1 pa-
tient was tachygastric (7.7%) in the postprandial period. Seven 
patients (53.8%) showed decreased postprandial PR.
However, the EGG parameters were not significantly differ-
ent depending on SCN5A mutation (Table 3).
Discussion
The hypothesis of our study was that mutation in the SCN5A 
gene may be related to dyspeptic symptoms and abnormalities of 
gastric myoelectrical activity in patients with Brugada syndrome 
and/or FD. Due to the limited number of patients in our study, 
we could not obtain significant differences in symptoms and/or 
EGG parameters depending on SCN5A mutation.
SCN5A encodes the molecular identity of the pore-forming α
-subunit of the tetrodotoxin-insensitive sodium channel in both 
human intestinal smooth muscle and cardiac myocytes.11 The role 
of a sodium channel is less well defined in smooth muscle and 
ICC of the GI tract. There is a report, however, that a mechano-
sensitive sodium current present in human intestinal ICC may 
play an important role in the normal physiological control of hu-
man intestinal motor function by contributing to the setting of the 
membrane potential, the rate of rise of the slow wave, and mecha-
nosensitive regulation of slow wave frequency.11 The electrical 
slow wave is generated from ICC. Blockers of the sodium current 
slow the rate of rise and decrease the frequency of the slow wave, 
while stretching of human circular smooth muscle strips for acti-
vation of the mechano-sensitive sodium channel which increases 
the frequency of the slow wave.11
Mutations in SCN5A that affect the electrical phenotype of 
the NaV1.5 channel may therefore alter the contribution of the so-
dium channel to the intrinsic electrical activity of the intestine and 
may result in abnormal intestinal motility.7 In other words, GI 
phasic mechanical contractions are preceded by changes in the 
electrical activity of smooth muscle cells.
It is a well-known fact that mutations in the SCN5A gene 
have been linked to a variety of diseases causing sudden cardiac 
death in cardiology. The sodium channel isoform NaV1.5, en-
coded by the SCN5A gene, is the predominant α-subunit in the 
heart, and plays a key role in the excitability of atrial and ven-
tricular cardiomyocytes. Mutations in SCN5A that result in de-
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fined electrophysiological abnormalities can be divided into 2 pri-
mary arrhythmogenic phenotypes in the heart.15 One is gain-of- 
function mutations to yield the LQT3 phenotype,16 and the other 
is loss-of-function mutations resulting in the BrS1 phenotype.17
One study reported that there is the possibility that both gain- 
and loss-of-function mutations involving the sodium channel 
may increase susceptibility to GI symptoms.7
They showed that subjects with an SCN5A mutation had 
more GI symptom complexes (OR 5.2; 95% CI, 1.5-18.3).7 
There is also a study that evaluated SCN5A as a candidate gene 
involved in the pathogenesis of irritable bowel syndrome (IBS).18 
These researchers recruited 49 subjects diagnosed with IBS and 
performed mutational analysis on their genomic DNA. They 
found that the G298S-SCN5A missense mutation caused a 
marked reduction of whole cell sodium current and loss of func-
tion of NaV1.5, and suggested the concept of an intestinal chan-
nelopathy resulting in IBS. However, we did not find specific 
symptom patterns according to mutation of SCN5A in patients 
with Brugada syndrome and FD.
There are several reports that suggest a close relationship be-
tween dyspeptic symptoms and myoelectrical abnormalities in-
cluding instability of the gastric pacemaker frequency, tachygas-
tria in both the fasting and postprandial states, or the absence of 
the normal amplitude increase in the postprandial period.19,20 
Therefore, we attempted to prove the possible relationship be-
tween SCN5A mutation and gut channelopathy by EGG analysis. 
A limitation of our study is that the number of subjects was 
too small. Although our institution is a tertiary referral center, 
there were only a few dozen people who could participate in this 
study because of the extremely low prevalence of Brugada 
syndrome.
Although we did not find statistically significant results both 
in symptoms and EGG parameters, it is meaningful to attempt to 
identify differences in gastric myoelectric activity according to the 
presence of SCN5A mutation. In order to demonstrate channel-
opathy as one of the pathophysiologic mechanism of FD, a 
large-scale multi-center study is needed in the future.
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